Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease.
Inter-patient and intra-patient variations in the baseline values of the tapping test were studied in 22 patients with Parkinson's disease using the unequal sample sizes model II one-way analysis of variance (ANOVA). The results show that intra-patient variation accounts for about 15.8% of the total variation, inter-patient variation accounts for about 84.2% of the total variation, and the coefficient of variation (CV) in intra-patient variation is 15.8%. The results suggest that at least two or three baseline tapping tests are needed to determine the baseline value of the tapping test.
Wu
G
G
Chair of Special Pharmacology, Medical School, University of Udine, Italy.
Baraldo
M
M
Furlanut
M
M
D000368:Aged; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D005385:Fingers / Q000503:physiopathology; D014644:Genetic Variation; D006801:Humans; D007980:Levodopa / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*; D011597:Psychomotor Performance / Q000187:drug effects; D015203:Reproducibility of Results; D012720:Severity of Illness Index
D000978:Antiparkinson Agents; D007980:Levodopa